← back to search

Elaine R. Peskind

University of Washington · US
Area of research
Physiology · Psychiatry and Mental health
Research interest
Research interests include Alzheimer's disease research and treatments, Dementia and Cognitive Impairment Research, Traumatic Brain Injury Research, and Traumatic Brain Injury and Neurovascular Disturbances.
h-index
113
citations
53,028
works
538
NIH funding
primary concept
email

Recent publications

APOE loss-of-function variants: Compatible with longevity and associated with resistance to Alzheimer’s disease pathology
Neuron 2024cited by 41position: middledoi
Inflammatory biomarkers for neurobehavioral dysregulation in former American football players: findings from the DIAGNOSE CTE Research Project
Journal of Neuroinflammation 2024cited by 14position: middledoi
Examination of plasma biomarkers of amyloid, tau, neurodegeneration, and neuroinflammation in former elite American football players
Alzheimer s & Dementia 2024cited by 11position: middledoi
Flortaucipir tau PET findings from former professional and college American football players in the DIAGNOSE CTE research project
Alzheimer s & Dementia 2023cited by 16position: middledoi
Blood extracellular vesicles carrying synaptic function‐ and brain‐related proteins as potential biomarkers for Alzheimer's disease
Alzheimer s & Dementia 2022cited by 74position: middledoi
SOBA: Development and testing of a soluble oligomer binding assay for detection of amyloidogenic toxic oligomers
Proceedings of the National Academy of Sciences 2022cited by 67position: middledoi
National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome
Neurology 2021cited by 319position: middledoi
Developing methods to detect and diagnose chronic traumatic encephalopathy during life: rationale, design, and methodology for the DIAGNOSE CTE Research Project
Alzheimer s Research & Therapy 2021cited by 87position: middledoi
State‐of‐the‐art of lumbar puncture and its place in the journey of patients with Alzheimer's disease
Alzheimer s & Dementia 2021cited by 75position: middledoi
Cognitive impairment and World Trade Centre-related exposures
Nature Reviews Neurology 2021cited by 52position: middledoi
Brain and blood biomarkers of tauopathy and neuronal injury in humans and rats with neurobehavioral syndromes following blast exposure
Molecular Psychiatry 2020cited by 96position: middledoi
Chronic elevation of plasma vascular endothelial growth factor-A (VEGF-A) is associated with a history of blast exposure
Journal of the Neurological Sciences 2020cited by 19position: lastdoi
The Extracellular RNA Communication Consortium: Establishing Foundational Knowledge and Technologies for Extracellular RNA Research
Cell 2019cited by 225position: middledoi
Sex differences in the genetic predictors of Alzheimer’s pathology
Brain 2019cited by 103position: middledoi
Sex-specific genetic predictors of Alzheimer’s disease biomarkers
Acta Neuropathologica 2018cited by 117position: middledoi
P1‐139: THE CONTRIBUTION OF SEX‐SPECIFIC ASSOCIATIONS IN GENETIC STUDIES OF ALZHEIMER'S DISEASE PATHOLOGY
Alzheimer s & Dementia 2018cited by 0position: middledoi
Genome-wide association study identifies four novel loci associated with Alzheimer’s endophenotypes and disease modifiers
Acta Neuropathologica 2017cited by 252position: middledoi
Biofluid biomarkers of traumatic brain injury
Brain Injury 2017cited by 193position: lastdoi
CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease
Alzheimer s & Dementia 2016cited by 212position: middledoi
Repetitive blast exposure in mice and combat veterans causes persistent cerebellar dysfunction
Science Translational Medicine 2016cited by 146position: middledoi
Blast exposure causes dynamic microglial/macrophage responses and microdomains of brain microvessel dysfunction
Neuroscience 2016cited by 79position: middledoi
Transcriptomic Profiling of Extracellular RNAs Present in Cerebrospinal Fluid Identifies Differentially Expressed Transcripts in Parkinson’s Disease
Journal of Parkinson s Disease 2016cited by 45position: middledoi
Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia
JAMA 2015cited by 200position: middledoi
Cerebrospinal Fluid Peptides as Potential Parkinson Disease Biomarkers: A Staged Pipeline for Discovery and Validation*
Molecular & Cellular Proteomics 2015cited by 71position: middledoi
Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease
Acta Neuropathologica 2014cited by 672position: middledoi
Agitation in cognitive disorders: International Psychogeriatric Association provisional consensus clinical and research definition
International Psychogeriatrics 2014cited by 350position: middledoi
GWAS of Cerebrospinal Fluid Tau Levels Identifies Risk Variants for Alzheimer’s Disease
Neuron 2013cited by 401position: middledoi
Antioxidants for Alzheimer Disease
Archives of Neurology 2012cited by 367position: middledoi
Phosphorylated α-Synuclein in Parkinson’s Disease
Science Translational Medicine 2012cited by 275position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jing Zhang · Hebei Medical University7 papers (2012–2022)Douglas Galasko · La Jolla Bioengineering Institute6 papers (2012–2022)Cyrus P. Zabetian · University of Washington6 papers (2012–2022)Min Shi · Cincinnati Children's Hospital Medical Center6 papers (2012–2022)Joseph F. Quinn · Oregon Health & Science University5 papers (2012–2022)William A. Banks · Harborview Medical Center4 papers (2014–2020) · 4 papers (2014–2022)Kathleen F. Pagulayan · Seattle University3 papers (2016–2020)Murray A. Raskind · University of Washington3 papers (2016–2020)Jeffrey L. Cummings · New York University3 papers (2014–2021)Shu-Ching Hu · University of Washington3 papers (2014–2016)Catherine Pan · National University of Singapore3 papers (2012–2022)Tessandra Stewart · University of Washington3 papers (2015–2022)Carmen Ginghină · University of Rochester2 papers (2014–2016)James S. Meabon · Seattle University2 papers (2016–2020)Constantine G. Lyketsos · Precision for Medicine (United States)2 papers (2014–2015)C. Dirk Keene · Seattle Pacific University2 papers (2020–2022)Anton P. Porsteinsson · University of Rochester Medical Center2 papers (2014–2015)Paul Aisen · University of Southern California2 papers (2012–2021)Cynthia Mayer · UK Dementia Research Institute2 papers (2016–2020)